Received Feb 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z008197 | OT / LL |
No side effects or symptoms reported.; HCP called to report TE where patient received product after it was improperly stored.; This spontaneous report was received from a Physician Assistant and referred to a 1-year-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 05-Nov-2025, the patient was vaccinated with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) 0.5 mL (lot #Z008197, expiration date: 30-Apr-2027) (0.5ml) (route of administration, anatomical location not provided) as Prophylaxis, which was improperly stored with a temperature at -10.5 degree Celsius (C) for 1 hour. The vaccine was reconstituted with sterile diluent (lot# and expiration date were not provided). No previous excursions reported, no side effects or symptoms reported. Follow up information was received from the Physician Assistant on 22-Jan-2026 and referred to a 1-year-old male patient. Reporters' details were updated. On 05-Nov-2025, the patient was vaccinated with the 1st dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) subcutaneously into left thigh.
sterile diluent